suPARnostic® aids in both triage and monitoring, as an early identifier of critical cases and aids in patient decisions - high and rising suPARnostic® level indicates a critical condition and increased risk of mortality, decreasing suPARnostic® indicates patient improvement and effective intervention.
suPARnostic® is measured by the suPARnostic® ELISA assay developed by ViroGates.
The suPARnostic® ELISA kit gets top marks from lab users: Performed in less than 2 hours, robust and yielding reproducible results, as ViroGates perform value transfer between batches. All reactions are at room temperature, all reagents are provided for convenience.

suPAR - the protein that reveals your risk for lifestyle diseases
Read the article in RASK Magasinet ..... ![]()
suPARnostic® partnered with new distributors
Comercial Rafer in Spain and Portugal, B.S.N. in Italy and Caltag Medsystems in UK....
suPAR on LinkedIn:
Look for the suPARnostic® group on LinkedIn